Select Page
Responsive Centered YouTube Video
Discussion on vaccine safety, challenges, and evolving opinions amidst the COVID-19 pandemic
  • Gert’s diverse background in veterinary medicine, virology, and vaccine development. 03:22
  • Involvement in vaccine projects at various organizations including Gates Foundation and GAVI. 05:18
  • Transition to focusing on natural killer cell vaccines before COVID-19 pandemic. 06:27
  • Impact of questioning vaccines on public perception and vaccine hesitancy. 07:03
  • Call for continuous improvement in vaccine safety and efficacy. 07:30
  • Acknowledgment of antivaccine movement and advocacy for safer vaccine practices. 07:37
  • Involvement in COVID-19 mass vaccination initiative and revising opinions on vaccines. 07:57
  • Focus on childhood immunization programs using live attenuated viruses. 08:17
  • Importance of stimulating cell-based innate immunity through vaccines. 08:26
Concerns raised regarding immune escape in vaccinated individuals and potential implications on pandemic transition
  • Vaccines stimulating cell-based innate immunity without life-threatening risks are sought. 8:44

  • Call for a reevaluation of the vaccine industry’s profit-driven motives and excessive vaccine doses. 9:30

  • Assertion that blame for immune escape pandemic transition cannot be solely placed on unvaccinated or revaccinated individuals. 10:37

  • Documentation of immune escape phenomenon by experts despite some public skepticism. 11:30

  • Illustration of spike protein mutations leading to variant emergence and potential vaccine evasion. 13:02

  • Discussion on the impact of mutations on the spike protein structure and viral evolution. 14:08

  • Technical analysis of spike protein mutations and their influence on viral behavior. 14:46

  • Intermittent internet interruptions causing communication challenges during the conversation. 15:06

Concerns raised about evolving immune response to COVID-19 and potential future challenges
  • Highly vaccinated societies may face unexpected challenges due to evolving antibodies. 15:31

  • Broadly neutralizing antibodies are less efficient than specifically neutralizing antibodies. 16:41

  • Cytotoxic T cells have a delayed response compared to antibodies in controlling infection. 21:57

Insight into immune response against evolving viruses and implications on viral transmission
  • Cells can only control virus infection once it enters and replicates inside the cell. 23:25

  • Cytotoxic T cells recognize and kill virus-infected cells, reducing viral production. 23:35

  • Evolution of the virus leads to suboptimal immune responses promoting immune escape. 23:45

  • Despite mild or asymptomatic disease, infected individuals can still spread the virus. 24:23

  • Universal peptide shared among different viruses limits viral production but drives mutations. 25:33

  • Mutations in various viral proteins aim to enhance transmission and evade immune pressure. 26:27

  • CTLs lack memory, reacting only when cells are infected, affecting virus clearance speed. 30:13

  • Memoryless CTLs allow mutations that improve viral replication and transmission to thrive. 30:33

  • Persistent viral spread due to mutations aiding in enhanced transmissibility despite immune response. 30:54

Implications of lacking memory T-cells in immune response to evolving variants
  • Memory T-cells do not develop for universal peptides due to self-mimicking nature, leading to ineffective immune response. 31:02

  • Virus mutations evade antibodies and memory T-cells, leaving cytotoxic T-lymphocytes as last line of defense. 35:06

  • Breakthrough infections may still protect against severe disease through non-neutralizing antibodies. 36:08

  • Concerns arise for new variants like Omicron using different entry mechanisms that could evade current vaccine responses. 37:54

Discussion on immune responses to new variants, impact on vaccine effectiveness, and potential risks
  • New variants like Omicron can trigger subacute COVID symptoms by reaching alveolar cells. 38:20

  • Virus breakthroughs slow down due to immune system compensation mechanisms. 38:54

  • Protection against severe disease is key as other defenses weaken over time. 40:02

  • Non-neutralizing antibodies bind to a conserved site, critical for defense against variants. 40:12

  • Glycosylation may be the only way to evade non-neutralizing antibodies’ protection. 41:05

  • Vaccination can lead to higher levels of non-neutralizing antibodies, impacting virus transmission. 43:07

  • Dominant virus lineages like gn1 affect virus absorption and immune responses. 43:48

  • Increased inflammation promotes virus absorption, reducing non-neutralizing antibody effectiveness. 45:00

  • Fewer CTL responses result in more CD4 T Cell responses, altering immune reactions. 46:03

Discussion on potential emergence of a new coronavirus with different protein profile and implications on immunity
  • Prediction of a new coronavirus with altered protein profile leading to a different type of virus. 46:12

  • Loss of helper function in CD4T cells may contribute to autoimmunity. 46:21

  • Decreased neutralizing antibodies due to loss of helper function in CD4T cells. 46:30

  • Increased consumption of antibodies by dominant mutants like gn1. 46:38

  • Suboptimal concentration of non-neutralizing antibodies affecting virulence prevention. 46:58

  • Shift in antibody response towards non-neutralizing antibodies against new variants. 47:40

  • Presence of subneutralizing antibodies with low Affinity and high avidity. 49:33

  • Discussion on potential emergence of a new influenza variant H1N1 with risk of human crossover. 51:46

  • Prediction of a new pandemic caused by a different coronavirus due to immune escape dynamics. 52:40

Analysis of immune responses to mass vaccination and virus evolution leading to potential risks
  • Mass vaccination during pandemic led to vaccine breakthrough infections and immune escape. 53:31

  • Continuous immune responses delayed resolution of problems, potentially benefiting non-vaccinated population. 53:38

  • Hyperactivated CTL responses due to SARS-CoV-2 infection may render other infections asymptomatic. 54:59

  • Disturbance in population immunity leading to consequences in restoring balance and emergence of new infectious diseases. 58:12

  • Complex interactions between immune responses, infections, and vaccinations impacting population immunity. 58:39

  • Potential risks of immune pathology and non-infectious diseases due to disrupted population immunity. 59:07

  • Increase in immune-mediated diseases like cancers due to large-scale immunodisregulation. 59:07

  • Overall, the interconnected nature of immune system responses and infections poses a complex puzzle. 59:15

  • Non-neutralizing antibodies may play a role in immune escape and vaccine ineffectiveness against Omicron. 1:00:06

Analysis of immune response dynamics, impact on viral evolution, and potential implications on disease severity
  • Low affinity binding of initially neutralizing antibodies leads to synthesis of non-neutralizing antibodies. 1:01:00

  • Non-neutralizing antibodies bind to spike protein, enhancing infection by accelerating receptor binding. 1:01:24

  • Vaccine breakthrough infections result in broadly neutralizing antibodies targeting conserved epitopes. 1:02:08

  • Shift in virus absorption to dendritic cells may reduce CTL activation, leading to immune pathology. 1:04:08

  • Increased transmissibility drives viral evolution towards resistance against neutralizing antibodies and enhanced infectivity. 1:06:06

  • Cryptic variants with resistance, infectivity, and productivity advantages outcompete less competitive strains. 1:07:04

Implications of highly transmissible Coronavirus mutations and potential immune evasion strategies
  • Virus reaching maximum transmissibility leads to intrahost spread within organs. 1:08:39

  • Evolution towards highly infective Coronavirus through steric immune silencing. 1:10:01

  • Glycosylation as a mechanism to hide antigenic sites and evade immune response. 1:11:26

  • Additional glycosylation may reduce virus fitness but enhance infectiousness. 1:12:00

  • Non-neutralizing antibodies may enhance severe disease due to infection enhancement. 1:13:59

  • Need for proactive antiviral measures to combat potential immune evasion strategies. 1:14:13

  • Host immune system resilience may have limitations in combating viral mutations. 1:15:13

  • Implications of Omicron variant highlight urgency in addressing neutralization challenges. 1:15:55

Impending warning of a potential catastrophic event due to immune exhaustion and vaccine breakthrough infections
  • Unexpected emergence of Omicron variant with significant mutations causing skepticism and conspiracy theories. 1:16:03

  • Anticipation of a new variant with similar impact as Omicron but focusing on immune evasion rather than infectivity. 1:16:43

  • Warning of imminent chaos in healthcare systems and society due to potential upcoming crisis. 1:18:30

  • Differentiating risk levels among unvaccinated individuals based on health status and lifestyle. 1:21:45

  • Highlighting increased vulnerability of elderly individuals due to early vaccination and potential immune escape with mRNA vaccines. 1:22:30

Impending threat of a new variant causing substantial losses due to mass vaccination and immune escape
  • Vaccinated individuals at highest risk with mRNA vaccines or multiple shots. 1:23:02

  • Innate immunity may not be sufficient against highly infectious variants. 1:23:42

  • Transition to a new phase of the pandemic is inevitable. 1:26:29

  • Mass vaccination causing immune pathology and immune escape. 1:27:11

  • Shift from antibody to cell-mediated immune responses leading to excess deaths. 1:28:00

  • Prediction of new variant impact before end of June. 1:29:29

Implications of potential rapid spread of antivirus prophylactics discussed, with willingness to face consequences for warning
  • Discussion on rapid spread of antivirus prophylactics in one country. 1:30:06

  • Expressed willingness to face consequences for warning about potential outcomes. 1:30:13

  • Emphasized importance of health and saving lives despite risks to reputation. 1:30:43